Alembic Pharma’s Q2FY24 Quarter Results

Alembic Pharma’s revenues grew over 9% YoY
  • 09 Nov 2023
  • Alembic Pharma reported 7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter ended September (Q2FY24). On a year-on-year (YoY) basis, it witnessed a growth of 9%.
  • Its expenses for the quarter were up by 7% QoQ and 11% YoY.
  • The net profit grew 13% QoQ and 2% YoY.
  • The earnings per share (EPS) of Alembic Pharma stood at 7 during Q2FY24.

Alembic Pharma’s Financial Statements for Q2FY24:

(Rs crores) Q2FY23 Q1FY24 Q2FY24 QoQ (%) YoY (%)
Total income1,4751,4981,6057%9%
Total expenses1,3221,3681,4707%11%
Profit before tax1511301354%-11%
Profit after tax13312113713%2%
Earnings per share6.86.17.0

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Open Demat Account
or Resume your Application
+91 -